Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 21

1.

Epigenetics, cardiovascular disease, and cellular reprogramming.

Al-Hasani K, Mathiyalagan P, El-Osta A.

J Mol Cell Cardiol. 2019 Mar;128:129-133. doi: 10.1016/j.yjmcc.2019.01.019. Epub 2019 Jan 25. Review.

PMID:
30690032
2.

Long-Term GABA Administration Induces Alpha Cell-Mediated Beta-like Cell Neogenesis.

Ben-Othman N, Vieira A, Courtney M, Record F, Gjernes E, Avolio F, Hadzic B, Druelle N, Napolitano T, Navarro-Sanz S, Silvano S, Al-Hasani K, Pfeifer A, Lacas-Gervais S, Leuckx G, Marroquí L, Thévenet J, Madsen OD, Eizirik DL, Heimberg H, Kerr-Conte J, Pattou F, Mansouri A, Collombat P.

Cell. 2017 Jan 12;168(1-2):73-85.e11. doi: 10.1016/j.cell.2016.11.002. Epub 2016 Dec 1.

3.

Determinants of Proteolysis and Cell-Binding for the Shigella flexneri Cytotoxin, SigA.

Chua EG, Al-Hasani K, Scanlon M, Adler B, Sakellaris H.

Curr Microbiol. 2015 Nov;71(5):613-7. doi: 10.1007/s00284-015-0893-8. Epub 2015 Aug 22.

PMID:
26297175
4.

Epigenetic-mediated reprogramming of pancreatic endocrine cells.

Mathiyalagan P, Keating ST, Al-Hasani K, El-Osta A.

Antioxid Redox Signal. 2015 Jun 1;22(16):1483-95. doi: 10.1089/ars.2014.6103. Epub 2015 Mar 18. Review.

PMID:
25621632
5.

Induction of multiple cycles of pancreatic β-cell replacement.

Pfeifer A, Courtney M, Ben-Othman N, Al-Hasani K, Gjernes E, Vieira A, Druelle N, Avolio F, Faurite B, Mansouri A, Collombat P.

Cell Cycle. 2013 Oct 15;12(20):3243-4. doi: 10.4161/cc.26357. Epub 2013 Sep 13. No abstract available.

6.

Adult duct-lining cells can reprogram into β-like cells able to counter repeated cycles of toxin-induced diabetes.

Al-Hasani K, Pfeifer A, Courtney M, Ben-Othman N, Gjernes E, Vieira A, Druelle N, Avolio F, Ravassard P, Leuckx G, Lacas-Gervais S, Ambrosetti D, Benizri E, Hecksher-Sorensen J, Gounon P, Ferrer J, Gradwohl G, Heimberg H, Mansouri A, Collombat P.

Dev Cell. 2013 Jul 15;26(1):86-100. doi: 10.1016/j.devcel.2013.05.018. Epub 2013 Jun 27.

7.

Screening of 71 P. multocida proteins for protective efficacy in a fowl cholera infection model and characterization of the protective antigen PlpE.

Hatfaludi T, Al-Hasani K, Gong L, Boyce JD, Ford M, Wilkie IW, Quinsey N, Dunstone MA, Hoke DE, Adler B.

PLoS One. 2012;7(7):e39973. doi: 10.1371/journal.pone.0039973. Epub 2012 Jul 5.

8.

In vivo conversion of adult α-cells into β-like cells: a new research avenue in the context of type 1 diabetes.

Courtney M, Pfeifer A, Al-Hasani K, Gjernes E, Vieira A, Ben-Othman N, Collombat P.

Diabetes Obes Metab. 2011 Oct;13 Suppl 1:47-52. doi: 10.1111/j.1463-1326.2011.01441.x. Review.

PMID:
21824256
9.

Outer membrane proteins of Pasteurella multocida.

Hatfaludi T, Al-Hasani K, Boyce JD, Adler B.

Vet Microbiol. 2010 Jul 29;144(1-2):1-17. doi: 10.1016/j.vetmic.2010.01.027. Epub 2010 Feb 4. Review.

PMID:
20197220
10.

The immunogenic SigA enterotoxin of Shigella flexneri 2a binds to HEp-2 cells and induces fodrin redistribution in intoxicated epithelial cells.

Al-Hasani K, Navarro-Garcia F, Huerta J, Sakellaris H, Adler B.

PLoS One. 2009 Dec 9;4(12):e8223. doi: 10.1371/journal.pone.0008223.

11.

Characterization of TolC efflux pump proteins from Pasteurella multocida.

Hatfaludi T, Al-Hasani K, Dunstone M, Boyce J, Adler B.

Antimicrob Agents Chemother. 2008 Nov;52(11):4166-71. doi: 10.1128/AAC.00245-08. Epub 2008 Aug 25.

12.

Genome sequence and identification of candidate vaccine antigens from the animal pathogen Dichelobacter nodosus.

Myers GS, Parker D, Al-Hasani K, Kennan RM, Seemann T, Ren Q, Badger JH, Selengut JD, Deboy RT, Tettelin H, Boyce JD, McCarl VP, Han X, Nelson WC, Madupu R, Mohamoud Y, Holley T, Fedorova N, Khouri H, Bottomley SP, Whittington RJ, Adler B, Songer JG, Rood JI, Paulsen IT.

Nat Biotechnol. 2007 May;25(5):569-75. Epub 2007 Apr 29.

PMID:
17468768
13.

Identification of novel immunogens in Pasteurella multocida.

Al-Hasani K, Boyce J, McCarl VP, Bottomley S, Wilkie I, Adler B.

Microb Cell Fact. 2007 Jan 18;6:3.

14.

A 191-kb genomic fragment containing the human alpha-globin locus can rescue alpha-thalassemic mice.

Al-Hasani K, Vadolas J, Knaupp AS, Wardan H, Voullaire L, Williamson R, Ioannou PA.

Mamm Genome. 2005 Nov;16(11):847-53. Epub 2005 Nov 11.

PMID:
16284800
15.

Complementation of alpha-thalassaemia in alpha-globin knockout mice with a 191 kb transgene containing the human alpha-globin locus.

Al-Hasani K, Vadolas J, Voullaire L, Williamson R, Ioannou PA.

Transgenic Res. 2004 Jun;13(3):235-43.

PMID:
15359601
16.

Regulated site-specific recombination of the she pathogenicity island of Shigella flexneri.

Sakellaris H, Luck SN, Al-Hasani K, Rajakumar K, Turner SA, Adler B.

Mol Microbiol. 2004 Jun;52(5):1329-36.

17.

Retrofitting bacterial artificial chromosomes by homologous recombination into enhanced BAC vectors for functional studies.

al-Hasani K, Ioannou P.

Biotechniques. 2003 Nov;35(5):1054-6, 1058. No abstract available.

18.

Development of a novel bacterial artificial chromosome cloning system for functional studies.

Al-Hasani K, Simpfendorfer K, Wardan H, Vadolas J, Zaibak F, Villain R, Ioannou PA.

Plasmid. 2003 Mar;49(2):184-7.

PMID:
12726772
19.

Distribution and structural variation of the she pathogenicity island in enteric bacterial pathogens.

Al-Hasani K, Adler B, Rajakumar K, Sakellaris H.

J Med Microbiol. 2001 Sep;50(9):780-6.

PMID:
11549179
20.

Genetic organization of the she pathogenicity island in Shigella flexneri 2a.

Al-Hasani K, Rajakumar K, Bulach D, Robins-Browne R, Adler B, Sakellaris H.

Microb Pathog. 2001 Jan;30(1):1-8.

PMID:
11162180
21.

The sigA gene which is borne on the she pathogenicity island of Shigella flexneri 2a encodes an exported cytopathic protease involved in intestinal fluid accumulation.

Al-Hasani K, Henderson IR, Sakellaris H, Rajakumar K, Grant T, Nataro JP, Robins-Browne R, Adler B.

Infect Immun. 2000 May;68(5):2457-63.

Supplemental Content

Loading ...
Support Center